Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001209191-21-053393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-25 | 2021-08-23 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $161.85 | -742 | 903.3K | -0.1% | -$120.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-23 | S | D | 742 | $161.85 | 903,326 | D | — | — | (F1) These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |